Common Shares Outstanding: The number of class A shares currently held by investors.
Telix Pharmaceuticals Limited (TLX) Common Shares Outstanding data is not available for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$605.98M |
|
$31.71M |
|
$390.29M |
|
$1.00B |
|
$218.30M |
|
$369.41M |
|
$407.24M |
|
$625.54M |
|
$374.85M |
|
$100.33M |
|
$374.85M |
|
|
Common Shares Outstanding |
-- |
| Cash Flow Statement Financials | |
$28.39M |
|
$-89.17M |
|
$421.50M |
|
$81.30M |
|
$468.62M |
|
$387.32M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|